Gut and Liver (Sep 2021)

Clinical Characteristics and Long-term Prognosis of Elderly-Onset Ulcerative Colitis in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea

  • Sang Hyoung Park,
  • Seung Kyu Jeong,
  • Ji Hyun Lee,
  • Kyoung Hoon Rhee,
  • Young-Ho Kim,
  • Sung Noh Hong,
  • Kyung Ho Kim,
  • Seung In Seo,
  • Jae Myung Cha,
  • Sun Yong Park,
  • Hyunju Park,
  • Joo Sung Kim,
  • Jong Pil Im,
  • Hyuk Yoon,
  • Sung Hoon Kim,
  • Jisun Jang,
  • Jeong Hwan Kim,
  • Seong O Suh,
  • Young Kyun Kim,
  • Byong Duk Ye,
  • Suk-Kyun Yang,
  • on behalf of the Songpa-Kangdong Inflammatory Bowel Disease (SK-IBD) Study Group

DOI
https://doi.org/10.5009/gnl20289
Journal volume & issue
Vol. 15, no. 5
pp. 742 – 751

Abstract

Read online

Background/Aims: We aimed to evaluate the clinical characteristics and long-term prognosis of elderly-onset ulcerative colitis (EOUC) in Korean patients over a 30-year period using a wellestablished population-based cohort in the Songpa-Kangdong district of Seoul, Korea. Methods: Clinical characteristics and prognosis were compared between two groups: EOUC, defined as UC diagnosed in individuals aged ≥60 years and non-EOUC (N-EOUC), defined as UC diagnosed in individuals aged 18 to 59 years. Results: We identified 99 patients with EOUC (10.3%) and 866 patients with N-EOUC (89.7%) between 1986 and 2015. During the median follow-up of 104.5 months, the overall exposure to medications was comparable between patients with EOUC and N-EOUC (p=0.091 for corticosteroids, p=0.794 for thiopurines, and p=0.095 for anti-tumor necrosis factor agents). The cumulative risks of disease outcomes were also comparable between patients with EOUC and N-EOUC (22.4% vs 30.4% for proximal disease extension [p=0.351], 11.9% vs 18.1% for hospitalization [p=0.240], and 2.3% vs 1.8% for colectomy [p=0.977]) at 10 years after diagnosis. Multivariate Cox regression analysis revealed that corticosteroid use at diagnosis was an independent predictor of proximal disease extension (hazard ratio [HR], 6.216; 95% confidence interval [CI], 1.314 to 28.826) and hospitalization (HR, 11.241; 95% CI, 3.027 to 41.742) in patients with EOUC. Conclusions: In this population-based study from Korea, the pattern of medication use seemed comparable between the EOUC and N-EOUC groups. Moreover, patients with EOUC and those with N-EOUC have a similar disease course in terms of proximal disease extension, hospitalization, and colectomy.

Keywords